[Inverse Psoriasis]

Overview

Journal Hautarzt

Specialty Dermatology

Date 2015 Apr 22

PMID 25896586

Citations 2

Authors

P Weisenseel

K Reich

Affiliations

Soon will be listed here.

Abstract

Inverse psoriasis is clinically defined by chronic inflammatory lesions in intertrigineous areas. Colonisation or infection with Candida ssp. or bacteria is common. The disease-related quality of life is significantly reduced especially regarding sexual behavior. After the exclusion of relevant differential diagnoses, therapy should be adapted to the clinical outcome and potential comorbidities. Substances which are efficacious in psoriasis vulgaris are generally efficacious in inverse psoriasis, but have to be used off-label. Controlled clinical studies are only available for topical ascomycin.

Citing Articles

Efficacy and Microbiota Modulation Induced by LimpiAL 2.5%, a New Medical Device for the Inverse Psoriasis Treatment.

Pietrangelo L, Dattola A, Magnifico I, Petronio Petronio G, Cutuli M, Venditti N Int J Mol Sci. 2023; 24(7).

PMID: 37047310 PMC: 10094358. DOI: 10.3390/ijms24076339.

Inverse Psoriasis: From Diagnosis to Current Treatment Options.

Micali G, Verzi A, Giuffrida G, Panebianco E, Musumeci M, Lacarrubba F Clin Cosmet Investig Dermatol. 2020; 12:953-959.

PMID: 32099435 PMC: 6997231. DOI: 10.2147/CCID.S189000.

References

Zeichner J . Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas. J Clin Aesthet Dermatol. 2010; 3(9):37-40. PMC: 2945847. View

Lebwohl M, Freeman A, Shane Chapman M, Feldman S, Hartle J, Henning A . Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004; 51(5):723-30. DOI: 10.1016/j.jaad.2004.07.011. View

Syed Z, Khachemoune A . Inverse psoriasis: case presentation and review. Am J Clin Dermatol. 2010; 12(2):143-6. DOI: 10.2165/11532060-000000000-00000. View

Carrascosa J, Soria X, Domingo H, Ferrandiz C . Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment. Dermatol Surg. 2007; 33(3):361-3. DOI: 10.1111/j.1524-4725.2007.33074.x. View

Lysell J, Tessma M, Nikamo P, Wahlgren C, Stahle M . Clinical characterisation at onset of childhood psoriasis - a cross sectional study in Sweden. Acta Derm Venereol. 2014; 95(4):457-61. DOI: 10.2340/00015555-1986. View

Prinz J . [The role of streptococci in psoriasis]. Hautarzt. 2009; 60(2):109-15. DOI: 10.1007/s00105-008-1661-5. View

Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J . Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb). 2012; 2(1):15. PMC: 3510394. DOI: 10.1007/s13555-012-0015-5. View

Kalb R, Bagel J, Korman N, Lebwohl M, Young M, Horn E . Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2008; 60(1):120-4. DOI: 10.1016/j.jaad.2008.06.041. View

Phan C, Sigal M, Esteve E, Reguiai Z, Barthelemy H, Beneton N . Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis. J Eur Acad Dermatol Venereol. 2014; 30(1):78-82. DOI: 10.1111/jdv.12850. View

10.

Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P . Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol. 2008; 22(4):431-6. DOI: 10.1111/j.1468-3083.2007.02457.x. View

11.

Rouzaud M, Sevrain M, Villani A, Barnetche T, Paul C, Richard M . Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol. 2014; 28 Suppl 5:17-26. DOI: 10.1111/jdv.12562. View

12.

Nast A, Boehncke W, Mrowietz U, Ockenfels H, Philipp S, Reich K . [S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges. 2011; 9 Suppl 2:S1-104. DOI: 10.1111/j.1610-0379.2011.07680.x. View

13.

Mafong E, Friedman P, Kauvar A, Bernstein L, Alexiades-Armenakas M, Geronemus R . Treatment of inverse psoriasis with the 308 nm excimer laser. Dermatol Surg. 2002; 28(6):530-2. DOI: 10.1046/j.1524-4725.2002.12005.x. View

14.

Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb A . Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004; 51(5):731-8. DOI: 10.1016/j.jaad.2004.06.010. View

15.

Saber M, Brassard D, Benohanian A . Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A. Arch Dermatol. 2011; 147(5):629-30. DOI: 10.1001/archdermatol.2011.111. View

16.

Veloso F . Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 20 Suppl 4:50-3. DOI: 10.1111/j.1365-2036.2004.02055.x. View

17.

Wollenberg A, Bieber T . Proactive therapy of atopic dermatitis--an emerging concept. Allergy. 2008; 64(2):276-8. DOI: 10.1111/j.1398-9995.2008.01803.x. View

18.

Farber E, Nall L . Perianal and intergluteal psoriasis. Cutis. 1992; 50(5):336-8. View